Receiving enteral or intravenous therapy of antifungal of interest (triazole, echinocandin, amphotericin) including prophylaxis indication and antifungal therapy started in another unit (wards, operating room) for the same infectious episode
Availability of suitable intravenous/intra-arterial access to facilitate sample collection
Written informed consent has been obtained from the patient or their next of kin (according to local regulatory statements for ethical conduct of research at each study site)
You may not be if
Aged \< 18 years of age
Pregnancy
Consent not obtained (according to local regulatory statements for ethical conduct of research at each study site)
Diagnosis with human immunodeficiency virus or hepatitis B or C or tuberculosis
Clareo Health | Screening Anti-Fungal Exposure in Intensive Care Units
